An Open-Label, Single-Dose, Randomized, Four-Way Crossover Study In Healthy Volunteers To Evaluate The Effects Of A Low, Medium And High Fat Evening Meal On The Pharmacokinetics Of Pregabalin Controlled Release Formulation As Compared To The Immediate Release Formulation.

Trial Profile

An Open-Label, Single-Dose, Randomized, Four-Way Crossover Study In Healthy Volunteers To Evaluate The Effects Of A Low, Medium And High Fat Evening Meal On The Pharmacokinetics Of Pregabalin Controlled Release Formulation As Compared To The Immediate Release Formulation.

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Jul 2014

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Epilepsy; Generalised anxiety disorder; Neuropathic pain; Pain; Postherpetic neuralgia
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 03 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 03 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Apr 2011 Status changed from not yet recruiting to active, no longer recruitingas reported by ClinicalTrials.gov (NCT01270815).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top